相关实验视频
Updated: Jul 9, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
898
血小板RNA生物标志物 - - 提卡格勒尔响应基因与血小板功能和心血管事件有关
Rachel A Myers1, Thomas L Ortel2, Alexander Waldrop2,3
1Duke Clinical Research Unit, Duke University School of Medicine, Durham NC (R.A.M.).
Arteriosclerosis, thrombosis, and vascular biology
|December 7, 2023
概括
对蒂卡格勒反应的血小板转录可以识别那些从蒂卡格勒治疗中获益最多的患者. 这种生物标志物可以预测心血管风险和血小板功能,有助于最佳的患者选择提卡格雷勒治疗.
科学领域:
- 心血管医学 心血管医学
- 药物基因组学 药物基因组学
- 血液学 血液学 血液学
背景情况:
- 鉴定最佳的提卡格勒勒候选药物是具有挑战性的,因为风险:益处的概况是可变的.
- 血小板功能和心血管风险评估需要改进生物标志物.
- 蒂卡格勒勒对血小板基因表达的影响为生物标志物发现提供了潜在的途径.
研究的目的:
- 为了识别对Ticagrelor敏感的血小板转录.
- 为了确定这些转录作为血小板功能的生物标志物.
- 评估它们在预测心血管风险和指导提卡格雷勒治疗中的有用性.
主要方法:
- 研究了健康的志愿者 (n=107) 和外周动脉疾病患者 (n=139).
- 通过RNA测序分析了在暴露于蒂卡格雷勒后血小板基因表达的变化.
- 一个复合得分 (Ticagrelor暴露签名) 被开发和验证.
- 分析了得分与血小板功能,出血,动脉样硬化和心血管事件的关联.
主要成果:
- 提卡格勒尔改变了3409个血小板转录;111个形成了提卡格勒尔暴露签名得分.
- 这一分数在用提卡格勒罗尔时增加,并且与P2Y12抑制效应相关.
- 在健康对照组中,较高的分数表明血小板功能较低和轻微出血.
- 在患者中,较低的得分与动脉样硬化和缺血事件增加有关.
结论:
- 适应蒂卡格勒的血小板转录作为血小板功能的生物标志物.
- 这些转录预测心血管风险,有助于提卡格雷勒治疗选择.
- 临床实用性在于优化Ticagrelor对个体患者的风险:益处比率.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
532
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
532
Formation of the Platelet Plug
6.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.4K
Clot Retraction and Fibrinolysis
6.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.2K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K

